Combination ACE inhibitor and angiotensin-receptor blocker therapy was better than monotherapy in nondiabetic renal disease
- PMID: 12954032
Combination ACE inhibitor and angiotensin-receptor blocker therapy was better than monotherapy in nondiabetic renal disease
Retraction in
-
Retraction. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.Ann Intern Med. 2009 Dec 15;151(12):897. doi: 10.7326/0003-4819-151-12-200912150-00022. Ann Intern Med. 2009. PMID: 20008771 No abstract available.
Comment on
-
Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.Lancet. 2003 Jan 11;361(9352):117-24. doi: 10.1016/S0140-6736(03)12229-5. Lancet. 2003. Retraction in: Lancet. 2009 Oct 10;374(9697):1226. doi: 10.1016/S0140-6736(09)61768-2. PMID: 12531578 Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Miscellaneous